BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35377522)

  • 1. Tumor-derived immunoglobulin like transcript 5 induces suppressive immunocyte infiltration in colorectal cancer.
    Shi W; Zhang F; Chen X; Wang S; Zhang H; Yang Z; Wang G; Zheng Y; Han Y; Sun Y; Gao A
    Cancer Sci; 2022 Jun; 113(6):1939-1954. PubMed ID: 35377522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression.
    Yang Z; Gao A; Shi W; Wang J; Zhang X; Xu Z; Xu T; Zheng Y; Sun Y; Yang F
    Onco Targets Ther; 2021; 14():4239-4254. PubMed ID: 34321889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL8 induces M2 macrophage polarization and inhibits CD8
    Shao Y; Lan Y; Chai X; Gao S; Zheng J; Huang R; Shi Y; Xiang Y; Guo H; Xi Y; Yang L; Yang T
    FASEB J; 2023 Oct; 37(10):e23173. PubMed ID: 37665572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAMPT-Driven M2 Polarization of Tumor-Associated Macrophages Leads to an Immunosuppressive Microenvironment in Colorectal Cancer.
    Hong SM; Lee AY; Kim BJ; Lee JE; Seon SY; Ha YJ; Ng JT; Yoon G; Lim SB; Morgan MJ; Cha JH; Lee D; Kim YS
    Adv Sci (Weinh); 2024 Apr; 11(14):e2303177. PubMed ID: 38308188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
    Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 7. Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages.
    Zhu M; Bai L; Liu X; Peng S; Xie Y; Bai H; Yu H; Wang X; Yuan P; Ma R; Lin J; Wu L; Huang M; Li Y; Luo Y
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.
    Cheruku S; Rao V; Pandey R; Rao Chamallamudi M; Velayutham R; Kumar N
    Int Immunopharmacol; 2023 Mar; 116():109569. PubMed ID: 36773572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltration of Apoptotic M2 Macrophage Subpopulation Is Negatively Correlated with the Immunotherapy Response in Colorectal Cancer.
    Liu R; Han C; Hu J; Zhang B; Luo W; Ling F
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.
    Zhu X; Liang R; Lan T; Ding D; Huang S; Shao J; Zheng Z; Chen T; Huang Y; Liu J; Pathak JL; Wei H; Wei B
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BST2 induced macrophage M2 polarization to promote the progression of colorectal cancer.
    He X; Chen H; Zhong X; Wang Y; Hu Z; Huang H; Zhao S; Wei P; Shi D; Li D
    Int J Biol Sci; 2023; 19(1):331-345. PubMed ID: 36594082
    [No Abstract]   [Full Text] [Related]  

  • 13. Low level of stromal lectin-like oxidized LDL receptor 1 and CD8
    Katayama C; Yokobori T; Ozawa N; Suga K; Shiraishi T; Okada T; Osone K; Katoh R; Suto T; Motegi Y; Ogawa H; Sano A; Sakai M; Sohda M; Erkhem-Ochir B; Gombodorj N; Katayama A; Oyama T; Shirabe K; Kuwano H; Saeki H
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1364. PubMed ID: 33675293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ID1 expressing macrophages support cancer cell stemness and limit CD8
    Shang S; Yang C; Chen F; Xiang RS; Zhang H; Dai SY; Liu J; Lv XX; Zhang C; Liu XT; Zhang Q; Lu SB; Song JW; Yu JJ; Zhou JC; Zhang XW; Cui B; Li PP; Zhu ST; Zhang HZ; Hua F
    Nat Commun; 2023 Nov; 14(1):7661. PubMed ID: 37996458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin-Like Transcript 5 Inhibits Macrophage-Mediated Bacterial Killing and Antigen Presentation During Sepsis.
    Ming S; Li M; Wu M; Zhang J; Zhong H; Chen J; Huang Y; Bai J; Huang L; Chen J; Lin Q; Liu J; Tao J; He D; Huang X
    J Infect Dis; 2019 Oct; 220(10):1688-1699. PubMed ID: 31250008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment.
    Li C; Song J; Guo Z; Gong Y; Zhang T; Huang J; Cheng R; Yu X; Li Y; Chen L; Ma X; Sun Y; Wang Y; Xue L
    Front Immunol; 2022; 13():857808. PubMed ID: 35432300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4/CXCL12 axis.
    Fang H; Huang Y; Luo Y; Tang J; Yu M; Zhang Y; Zhong M
    Cell Immunol; 2022 Jan; 371():104458. PubMed ID: 34847407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
    Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.